Cryosite Ltd
ASX:CTE

Watchlist Manager
Cryosite Ltd Logo
Cryosite Ltd
ASX:CTE
Watchlist
Price: 0.85 AUD Market Closed
Market Cap: 41.5m AUD
Have any thoughts about
Cryosite Ltd?
Write Note

Cryosite Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cryosite Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Cryosite Ltd
ASX:CTE
Accounts Receivables
AU$1.4m
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
-3%
Anteotech Ltd
ASX:ADO
Accounts Receivables
AU$206.9k
CAGR 3-Years
-5%
CAGR 5-Years
23%
CAGR 10-Years
-1%
Proteomics International Laboratories Ltd
ASX:PIQ
Accounts Receivables
AU$250.6k
CAGR 3-Years
-1%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Accounts Receivables
AU$20.2m
CAGR 3-Years
25%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Genetic Signatures Ltd
ASX:GSS
Accounts Receivables
AU$4.5m
CAGR 3-Years
-6%
CAGR 5-Years
39%
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Accounts Receivables
AU$2.6m
CAGR 3-Years
8%
CAGR 5-Years
2%
CAGR 10-Years
N/A
No Stocks Found

Cryosite Ltd
Glance View

Market Cap
41.5m AUD
Industry
Life Sciences Tools & Services

Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The firm engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.

CTE Intrinsic Value
0.67 AUD
Overvaluation 21%
Intrinsic Value
Price

See Also

What is Cryosite Ltd's Accounts Receivables?
Accounts Receivables
1.4m AUD

Based on the financial report for Jun 30, 2024, Cryosite Ltd's Accounts Receivables amounts to 1.4m AUD.

What is Cryosite Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-3%

Over the last year, the Accounts Receivables growth was -21%. The average annual Accounts Receivables growth rates for Cryosite Ltd have been -7% over the past three years , 10% over the past five years , and -3% over the past ten years .

Back to Top